Astrana Health (NASDAQ:ASTH) Price Target Cut to $50.00 by Analysts at Robert W. Baird

Astrana Health (NASDAQ:ASTH) had its price objective cut by Robert W. Baird from $86.00 to $50.00 in a report released on Monday morning,Benzinga reports. They currently have an outperform rating on the stock.

Other analysts have also issued research reports about the company. Truist Financial decreased their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Macquarie upgraded shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $58.40.

Astrana Health Stock Performance

Shares of ASTH opened at $26.48 on Monday. Astrana Health has a 12-month low of $23.12 and a 12-month high of $63.20. The stock has a market cap of $1.49 billion, a P/E ratio of 20.37, a PEG ratio of 1.37 and a beta of 1.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average of $34.84 and a two-hundred day moving average of $44.46.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The company had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, research analysts predict that Astrana Health will post 1.15 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Several hedge funds have recently modified their holdings of ASTH. Nisa Investment Advisors LLC purchased a new position in Astrana Health during the third quarter worth approximately $35,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Astrana Health during the 4th quarter worth $40,000. Quarry LP raised its position in shares of Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after buying an additional 471 shares during the period. KBC Group NV acquired a new position in Astrana Health in the third quarter valued at $70,000. Finally, Quest Partners LLC purchased a new stake in Astrana Health during the third quarter valued at about $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.